Carol A. Lange

12.9k total citations · 4 hit papers
140 papers, 10.4k citations indexed

About

Carol A. Lange is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Carol A. Lange has authored 140 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Genetics, 72 papers in Oncology and 65 papers in Molecular Biology. Recurrent topics in Carol A. Lange's work include Estrogen and related hormone effects (86 papers), Cytokine Signaling Pathways and Interactions (45 papers) and Melanoma and MAPK Pathways (19 papers). Carol A. Lange is often cited by papers focused on Estrogen and related hormone effects (86 papers), Cytokine Signaling Pathways and Interactions (45 papers) and Melanoma and MAPK Pathways (19 papers). Carol A. Lange collaborates with scholars based in United States, Germany and Chile. Carol A. Lange's co-authors include Gary L. Johnson, Kathryn B. Horwitz, Jeffrey A. Simon, Andrea R. Daniel, Anne M. Gardner, Emily J. Faivre, Audrey Minden, Michael Karin, Tianjie Shen and Anning Lin and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Carol A. Lange

136 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Activation of ERK and JNK Mitogen-Activated Protein Kinases by Raf-1 and MEKK

1994 998 citations Carol A. Lange, Gary L. Johnson et al. profile →
A Divergence in the MAP Kinase Regulatory Network Defined by MEK Kinase and Raf

1993 973 citations Carol A. Lange, Anne M. Gardner et al. profile →
Identification of a Dual Specificity Kinase That Activates the Jun Kinases and p38-Mpk2

1995 706 citations Carol A. Lange, Gary L. Johnson et al. profile →
Roles of the EZH2 histone methyltransferase in cancer epigenetics

2008 685 citations Jeffrey A. Simon, Carol A. Lange Mutation research. Fundamental and molecular mechanisms of mutagenesis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol A. Lange United States	53	6.5k	3.4k	3.3k	1.7k	1.3k	140	10.4k
Leigh C. Murphy Canada	62	5.7k 0.9×	3.2k 0.9×	4.6k 1.4×	2.0k 1.2×	1.1k 0.8×	207	10.5k
Jennifer K. Richer United States	46	4.1k 0.6×	2.4k 0.7×	2.9k 0.9×	2.5k 1.5×	876 0.7×	107	7.4k
Jiemin Wong United States	62	11.2k 1.7×	1.9k 0.6×	3.5k 1.1×	1.6k 1.0×	891 0.7×	150	13.8k
Rakesh Kumar United States	47	4.6k 0.7×	2.2k 0.7×	1.7k 0.5×	1.2k 0.7×	428 0.3×	160	7.1k
Michael R. Stallcup United States	58	10.1k 1.5×	1.7k 0.5×	4.8k 1.5×	1.1k 0.6×	1.2k 1.0×	147	13.6k
Henri Rochefort France	68	6.7k 1.0×	3.5k 1.1×	5.9k 1.8×	3.9k 2.3×	943 0.7×	266	13.5k
Alessandro Weisz Italy	47	4.8k 0.7×	1.4k 0.4×	2.1k 0.6×	2.0k 1.2×	981 0.8×	186	7.7k
Robert J. Matusik United States	51	5.7k 0.9×	1.8k 0.5×	2.2k 0.7×	1.6k 0.9×	831 0.7×	147	9.7k
Hallgeir Rui United States	50	3.1k 0.5×	3.5k 1.0×	894 0.3×	1.3k 0.8×	1.4k 1.1×	204	6.8k
Zafar Nawaz United States	47	4.8k 0.7×	1.3k 0.4×	3.9k 1.2×	732 0.4×	606 0.5×	113	7.6k

Countries citing papers authored by Carol A. Lange

Since Specialization

Citations

This map shows the geographic impact of Carol A. Lange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Lange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Lange more than expected).

Fields of papers citing papers by Carol A. Lange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Lange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Lange. The network helps show where Carol A. Lange may publish in the future.

Co-authorship network of co-authors of Carol A. Lange

This figure shows the co-authorship network connecting the top 25 collaborators of Carol A. Lange. A scholar is included among the top collaborators of Carol A. Lange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol A. Lange. Carol A. Lange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gillis, Noelle E., et al.. (2024). Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 243. 106575–106575. 1 indexed citations

Cain, Derek W., John A. Cidlowski, Dean P. Edwards, et al.. (2023). 3C. 3-Ketosteroid receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023(1). 1 indexed citations

Dwyer, Amy R., Thu H. Truong, Raisa I. Krutilina, et al.. (2023). Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4. Endocrinology. 164(7). 22 indexed citations

Truong, Thu H., Nuri A. Temiz, Ying Wang, et al.. (2021). PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer. Oncogene. 40(25). 4384–4397. 26 indexed citations

Lange, Carol A. & Stephen R. Hammes. (2021). Publish or Perish: Five Steps to Navigating a Less Painful Peer Review. Endocrinology. 162(3). 3 indexed citations

Dwyer, Amy R., Raisa I. Krutilina, Deanna N. Parke, et al.. (2020). Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling. Molecular Cancer Research. 19(2). 329–345. 16 indexed citations

Truong, Thu H., Nuri A. Temiz, Brian J. Girard, et al.. (2018). Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes. Molecular Cancer Research. 16(4). 707–719. 20 indexed citations

Truong, Thu H., et al.. (2018). Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates. Endocrinology. 160(2). 430–446. 40 indexed citations

Shi, Hong, Ganesh V. Raj, John A. Cidlowski, et al.. (2016). Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer. Cancer Research. 76(6). 1653–1663. 40 indexed citations

10.

Diep, Caroline H., Todd P. Knutson, & Carol A. Lange. (2015). Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Molecular Cancer Research. 14(2). 141–162. 25 indexed citations

11.

Peacock, Danielle L., Andrea R. Daniel, Kristopher A. Lofgren, et al.. (2013). Breast Tumor Kinase (Brk/PTK6) Is a Mediator of Hypoxia-Associated Breast Cancer Progression. Cancer Research. 73(18). 5810–5820. 48 indexed citations

12.

Hagan, Christy R., Todd P. Knutson, & Carol A. Lange. (2013). A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. Nucleic Acids Research. 41(19). 8926–8942. 39 indexed citations

13.

Díaz, Jorge, Evelyn Aranda, Soledad Henríquez, et al.. (2012). Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1. Journal of Endocrinology. 214(2). 165–175. 22 indexed citations

14.

Knutson, Todd P., Andrea R. Daniel, Danhua Fan, et al.. (2012). Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression. Breast Cancer Research. 14(3). R95–R95. 85 indexed citations

15.

Castro, Nancy & Carol A. Lange. (2010). Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells. Breast Cancer Research. 12(4). R60–R60. 59 indexed citations

16.

Lange, Carol A. & Douglas Yee. (2009). Progesterona y cáncer de mama. 12(71). 153–165. 1 indexed citations

17.

Simon, Jeffrey A. & Carol A. Lange. (2008). Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 647(1-2). 21–29. 685 indexed citations breakdown →

18.

Lange, Carol A. & Kimberly K. Leslie. (2005). Cáncer de mama y embarazo. 32(4). 547–558.

19.

Lange, Carol A. & Gary L. Johnson. (1995). [30] Assay of MEK kinases. Methods in enzymology on CD-ROM/Methods in enzymology. 255. 290–301. 18 indexed citations

20.

Gardner, Anne M., Carol A. Lange, Rosaire Vaillancourt, & Gary L. Johnson. (1994). [22] Measuring activation of kinases in mitogen-activated protein kinase regulatory network. Methods in enzymology on CD-ROM/Methods in enzymology. 238. 258–270. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact